Search company, investor...

Medvance Clinical Research


Acquired | Acquired

About Medvance Clinical Research

Medvance is a full service contract research organisation (CRO) specialized in medical devices, in-vitro diagnostics (IVDs), and combination products. For over 16 years, Medvance has been helping medical device companies provide patients with quality medical technology that improves health and quality of life.

Headquarters Location

Medvance House, Burn Grange, Doncaster Road Burn, Selby

North Yorkshire, YO8 8LA,

United Kingdom

+ 44 (0) 1757 270044

Missing: Medvance Clinical Research's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Medvance Clinical Research's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Medvance Clinical Research Frequently Asked Questions (FAQ)

  • Where is Medvance Clinical Research's headquarters?

    Medvance Clinical Research's headquarters is located at Medvance House, Burn Grange, Doncaster Road, North Yorkshire.

  • What is Medvance Clinical Research's latest funding round?

    Medvance Clinical Research's latest funding round is Acquired.

  • Who are the investors of Medvance Clinical Research?

    Investors of Medvance Clinical Research include North American Science Associates.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.